FR2643M - Nouveaux médicaments a base de 17-oxo-a-nor-5 α-androstane-2-ols substitués. - Google Patents

Nouveaux médicaments a base de 17-oxo-a-nor-5 α-androstane-2-ols substitués.

Info

Publication number
FR2643M
FR2643M FR938034A FR938034A FR2643M FR 2643 M FR2643 M FR 2643M FR 938034 A FR938034 A FR 938034A FR 938034 A FR938034 A FR 938034A FR 2643 M FR2643 M FR 2643M
Authority
FR
France
Prior art keywords
androstane
ols
oxo
substituted
new drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR938034A
Other languages
English (en)
Inventor
Jean Jacques
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR927934A external-priority patent/FR1519489A/fr
Application filed by Individual filed Critical Individual
Priority to ES0297634A priority Critical patent/ES297634A1/es
Application granted granted Critical
Publication of FR2643M publication Critical patent/FR2643M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
FR938034A 1962-03-15 1963-06-13 Nouveaux médicaments a base de 17-oxo-a-nor-5 α-androstane-2-ols substitués. Expired FR2643M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES0297634A ES297634A1 (es) 1963-03-14 1964-03-14 Procedimiento de obtencion de un material de revestimiento para combustible nuclear

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18001062A 1962-03-15 1962-03-15
US26375063A 1963-03-08 1963-03-08
FR927934A FR1519489A (fr) 1963-03-14 1963-03-14 Nouveaux 17-oxygéné-a-nor-5alpha-androstane-2-ols substitués

Publications (1)

Publication Number Publication Date
FR2643M true FR2643M (fr) 1964-07-06

Family

ID=26875906

Family Applications (1)

Application Number Title Priority Date Filing Date
FR938034A Expired FR2643M (fr) 1962-03-15 1963-06-13 Nouveaux médicaments a base de 17-oxo-a-nor-5 α-androstane-2-ols substitués.

Country Status (4)

Country Link
CH (1) CH442292A (fr)
DE (1) DE1468069A1 (fr)
DK (1) DK105112C (fr)
FR (1) FR2643M (fr)

Also Published As

Publication number Publication date
DE1468069A1 (de) 1969-06-04
DK105112C (da) 1966-08-22
CH442292A (de) 1967-08-31

Similar Documents

Publication Publication Date Title
FR3522M (fr) Médicament a base de benzamides substitués.
FR3215M (fr) Nouveaux médicaments a base de dérivés de dibenzocycloheptene.
FR3475M (fr) Médicament a base de diphényl-amino-éthylamine.
FR2239M (fr) Médicaments a base de dialcoyl-aminoalcoyl-pipéridines.
FR3142M (fr) Nouveaux médicaments a base de calcitonine.
FR3193M (fr) Nouveaux médicaments a base de dibenzocycloheptenes substitués.
FR2831M (fr) Médicament a base de pancréas.
FR1827M (fr) Médicament a base de 1.5-benzo-dioxépannes.
FR3790M (fr) Nouveaux médicaments a base de 2-alkyl-4-alkylamino-6-alkoxy-s-triazines.
FR2555M (fr) Médicament a base de substance antibiotique.
FR2231M (fr) Médicament a base de nouvelles dibenzothiéphinnes.
FR2201M (fr) Médicaments nouveaux a base de pyrimidinones.
FR2643M (fr) Nouveaux médicaments a base de 17-oxo-a-nor-5 α-androstane-2-ols substitués.
FR2957M (fr) Médicaments a base de peptides.
FR3235M (fr) Médicament a base de sulfanilamido-pyrimidine.
FR3033M (fr) Médicaments a base de sulfapyridines.
FR2992M (fr) Médicament a base de 2.4-diamino-6-hydroxyméthyl-7.8-dihydro-ptéridine.
FR2516M (fr) Nouveaux médicaments a base de dibenzocycloheptenes substitués.
FR3232M (fr) Nouveaux médicaments a base de dihydroxynitrate de bismuth.
FR2577M (fr) Médicament a base de naphtyl-amino-imidazoline.
FR2222M (fr) Nouveaux médicaments a base de benzenesulfonyl-semicarbazides.
FR3162M (fr) Médicament a base de sulfapyrimidines.
FR3861M (fr) Nouveaux médicaments a base de stéroides.
FR2572M (fr) Médicaments a base de nouveaux stéroides.
FR3122M (fr) Médicament a base de substance antibiotique.